AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 1 filers reported holding AKCEA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $452,000 | +32.9% | 24,900 | +0.4% | 0.00% | 0.0% |
| Q2 2020 | $340,000 | +21.0% | 24,808 | +26.4% | 0.00% | 0.0% |
| Q1 2020 | $281,000 | -14.6% | 19,624 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $329,000 | +11.5% | 19,400 | +1.3% | 0.00% | 0.0% |
| Q3 2019 | $295,000 | -34.3% | 19,150 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $449,000 | -23.1% | 19,150 | -7.0% | 0.00% | 0.0% |
| Q1 2019 | $584,000 | -1.4% | 20,602 | +4.9% | 0.00% | 0.0% |
| Q4 2018 | $592,000 | -14.0% | 19,645 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $688,000 | +48.6% | 19,645 | +0.7% | 0.00% | 0.0% |
| Q2 2018 | $463,000 | -22.1% | 19,516 | -15.8% | 0.00% | 0.0% |
| Q1 2018 | $594,000 | +43.8% | 23,179 | -2.6% | 0.00% | 0.0% |
| Q4 2017 | $413,000 | -38.5% | 23,800 | -2.1% | 0.00% | 0.0% |
| Q3 2017 | $672,000 | – | 24,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
| BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
| Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
| Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
| Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
| ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
| Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
| Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
| FMR LLC | 9,981,244 | $173,274,000 | 0.02% |